Mengmeng Dou
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine 3
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
-
- Biological and pharmacological studies of plants 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- Epigenetics and DNA Methylation 5
- Bioactive natural compounds 4
- RNA modifications and cancer 3
- Journals
- PLoS ONE (2 papers)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Mengmeng Dou
30 papers receiving 591 citations
Peers
Comparison fields: 5 of 87
- Geriatrics and Gerontology 31
- Cancer Research 108
- Pharmacology 83
- Neurology 39
- Molecular Biology 322
Countries citing papers authored by Mengmeng Dou
This map shows the geographic impact of Mengmeng Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Dou more than expected).
Fields of papers citing papers by Mengmeng Dou
This network shows the impact of papers produced by Mengmeng Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Dou. The network helps show where Mengmeng Dou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengmeng Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 15 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 17 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 29 | |
| 12 | 2019 | 11 | |
| 13 | 2018 | 6 | |
| 14 | 2018 | 9 | |
| 15 | 2017 | 24 | |
| 16 | 2017 | 21 | |
| 17 | 2016 | 12 | |
| 18 | 2016 | 65 | |
| 19 | 2016 | 11 | |
| 20 | 2014 | 30 |
About Mengmeng Dou
Mengmeng Dou is a scholar working on Geriatrics and Gerontology, Cancer Research and Neurology, having authored 31 papers that have together received 597 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Bioactive natural compounds (4 papers), Biological and pharmacological studies of plants (3 papers), MicroRNA in disease regulation (3 papers), Sirtuins and Resveratrol in Medicine (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Geriatrics and Gerontology (31 citations), Cancer Research (108 citations) and Pharmacology (83 citations). Mengmeng Dou has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Xiaoyan Zhao, Xueliang Zhou, Lifeng Li, Duoduo Zhang, Zhubo Li, Jie Zhang, Weijie Zhang, Lin Zhu, Liuxing Wang and Yaojuan Chu. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.